135 related articles for article (PubMed ID: 28720587)
1. Platelet soluble CD40-ligand level is associated with transfusion adverse reactions in a mixed threshold-and-hit model.
Cognasse F; Sut C; Fromont E; Laradi S; Hamzeh-Cognasse H; Garraud O
Blood; 2017 Sep; 130(11):1380-1383. PubMed ID: 28720587
[No Abstract] [Full Text] [Related]
2. Cytokines and related molecules, and adverse reactions related to platelet concentrate transfusions.
Cognasse F; Garraud O
Transfus Clin Biol; 2019 Sep; 26(3):144-146. PubMed ID: 31327557
[TBL] [Abstract][Full Text] [Related]
3. Evidence of CD40L/CD40 pathway involvement in experimental transfusion-related acute lung injury.
Tariket S; Hamzeh-Cognasse H; Laradi S; Arthaud CA; Eyraud MA; Bourlet T; Berthelot P; Garraud O; Cognasse F
Sci Rep; 2019 Aug; 9(1):12536. PubMed ID: 31467410
[TBL] [Abstract][Full Text] [Related]
4. The causes and treatment of reactions to platelet transfusions.
Blumberg N; Phipps RP; Kaufman J; Heal JM
Transfusion; 2003 Feb; 43(2):291-2; author reply 292. PubMed ID: 12559029
[No Abstract] [Full Text] [Related]
5. Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand.
Cognasse F; Payrat JM; Corash L; Osselaer JC; Garraud O
Blood; 2008 Dec; 112(12):4779-80; author reply 4780-1. PubMed ID: 19029460
[No Abstract] [Full Text] [Related]
6. The signaling role of CD40 ligand in platelet biology and in platelet component transfusion.
Aloui C; Prigent A; Sut C; Tariket S; Hamzeh-Cognasse H; Pozzetto B; Richard Y; Cognasse F; Laradi S; Garraud O
Int J Mol Sci; 2014 Dec; 15(12):22342-64. PubMed ID: 25479079
[TBL] [Abstract][Full Text] [Related]
7. An animal model of transfusion-related acute lung injury and the role of soluble CD40 ligand.
Hu A; Chen W; Wu S; Pan B; Zhu A; Yu X; Huang Y
Vox Sang; 2020 May; 115(4):303-313. PubMed ID: 32064628
[TBL] [Abstract][Full Text] [Related]
8. A computerized prediction model of hazardous inflammatory platelet transfusion outcomes.
Nguyen KA; Hamzeh-Cognasse H; Sebban M; Fromont E; Chavarin P; Absi L; Pozzetto B; Cognasse F; Garraud O
PLoS One; 2014; 9(5):e97082. PubMed ID: 24830754
[TBL] [Abstract][Full Text] [Related]
9. The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst.
Xie RF; Hu P; Li W; Ren YN; Yang J; Yang YM; Wang ZY; Fan HH
Vox Sang; 2014 Apr; 106(3):234-41. PubMed ID: 24138005
[TBL] [Abstract][Full Text] [Related]
10. Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes.
Refaai MA; Phipps RP; Spinelli SL; Blumberg N
Thromb Res; 2011 Apr; 127(4):287-91. PubMed ID: 21093892
[TBL] [Abstract][Full Text] [Related]
11. Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions.
Hamzeh-Cognasse H; Damien P; Nguyen KA; Arthaud CA; Eyraud MA; Chavarin P; Absi L; Osselaer JC; Pozzetto B; Cognasse F; Garraud O
Transfusion; 2014 Mar; 54(3):613-25. PubMed ID: 23944651
[TBL] [Abstract][Full Text] [Related]
12. CD40 ligand (CD154) involvement in platelet transfusion reactions.
Sahler J; Spinelli S; Phipps R; Blumberg N
Transfus Clin Biol; 2012 Jun; 19(3):98-103. PubMed ID: 22703674
[TBL] [Abstract][Full Text] [Related]
13. Platelet and TRALI: From blood component to organism.
Tariket S; Sut C; Hamzeh-Cognasse H; Laradi S; Garraud O; Cognasse F
Transfus Clin Biol; 2018 Sep; 25(3):204-209. PubMed ID: 29631963
[TBL] [Abstract][Full Text] [Related]
14. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion.
Phipps RP; Kaufman J; Blumberg N
Lancet; 2001 Jun; 357(9273):2023-4. PubMed ID: 11438137
[No Abstract] [Full Text] [Related]
15. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions.
Blumberg N; Gettings KF; Turner C; Heal JM; Phipps RP
Transfusion; 2006 Oct; 46(10):1813-21. PubMed ID: 17002639
[TBL] [Abstract][Full Text] [Related]
16. Platelet transfusion alters CD40L blood level and release capacity in patients suffering from thrombocytopenia.
Wenzel F; Günther W; Baertl A; Gruber W; Sorg RV; Haas R; Giers G
Transfusion; 2012 Jun; 52(6):1213-20. PubMed ID: 22082313
[TBL] [Abstract][Full Text] [Related]
17. Determination of predictors of severity for recipient adverse reactions during platelet product transfusions.
Sut C; Tariket S; Cognasse F; Garraud O
Transfus Clin Biol; 2017 Jun; 24(2):87-91. PubMed ID: 28479028
[TBL] [Abstract][Full Text] [Related]
18. Acute haemolytic reaction secondary to an ABO minor mismatched platelet transfusion from a group A blood donor.
Swain F; Daly J; Baidya S; Wilson B; Morrison J; Liew YW; Powley T; Jivan Y; Bryant S; Allen A; Crampton N
Transfus Med; 2019 Apr; 29(2):133-135. PubMed ID: 30900358
[No Abstract] [Full Text] [Related]
19. [Establishment of An Animal Model of Transfusion-related Acute Lung Injury and the Role of Soluble CD40 Ligand in the Development of Transfusion-related Acute Lung Injury].
Hu A; Chen WY; Huang YG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Aug; 40(4):439-443. PubMed ID: 30193594
[TBL] [Abstract][Full Text] [Related]
20. ABO-incompatible platelets are associated with increased transfusion reaction rates.
Malvik N; Leon J; Schlueter AJ; Wu C; Knudson CM
Transfusion; 2020 Feb; 60(2):285-293. PubMed ID: 31912889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
